These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 467810)

  • 21. Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrates tolerance.
    Chen M; Robertson RP
    Prostaglandins; 1979 Oct; 18(4):557-67. PubMed ID: 394200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP.
    Giugliano D; Cozzolino D; Ceriello A; Salvatore T; Paolisso G; Torella R
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E361-6. PubMed ID: 2551176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of in vivo insulin secretion by prostaglandin E1.
    Robertson RP; Gavareski DJ; Porte D; Bierman EL
    J Clin Invest; 1974 Aug; 54(2):310-5. PubMed ID: 4847247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin causes tissue insensitivity to insulin in normal man.
    Newman WP; Brodows RG
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1102-6. PubMed ID: 6355137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of lysine acetyl-salicylate on glucose and arginine stimulated insulin release in man.
    van Haeften TW; Veneman TF; van der Veen EA
    Horm Metab Res; 1991 Apr; 23(4):168-70. PubMed ID: 1908430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog.
    Robertson RP; Guest RJ
    J Clin Invest; 1978 Nov; 62(5):1014-9. PubMed ID: 361755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion is cultured pancreas.
    Metz SA; Robertson RP; Fujimoto WY
    Diabetes; 1981 Jul; 30(7):551-7. PubMed ID: 7018961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
    Lerner RL; Porte D
    J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandins, glucose homeostasis, and diabetes mellitus.
    Robertson RP
    Annu Rev Med; 1983; 34():1-12. PubMed ID: 6344749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The augmentation effects of secretin on the insulin responses to known stimuli: specificity for glucose.
    Lerner RL
    J Clin Endocrinol Metab; 1977 Jul; 45(1):1-9. PubMed ID: 874055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Furosemide causes acute and long-term hyperglycaemia and reduces glucose tolerance in mice.
    Sandström PE; Sehlin J
    Acta Physiol Scand; 1988 Jan; 132(1):75-81. PubMed ID: 3066121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man.
    Giugliano D; Torella R; Improta L; D'Onofrio F
    Diabete Metab; 1978 Sep; 4(3):187-91. PubMed ID: 710679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epinephrine: selective inhibition of the acute insulin response to glucose.
    Lerner RL; Porte D
    J Clin Invest; 1971 Nov; 50(11):2453-7. PubMed ID: 4938132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin and insulin secretion in man. III - Lack of interaction with prostaglandins.
    Giugliano D; Passariello N; Torella R; Gentile S; D'Angelo G
    Farmaco Sci; 1980 Jul; 35(7):615-20. PubMed ID: 6108875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration.
    Kalhan SC; Adam PA
    J Clin Endocrinol Metab; 1975 Sep; 41(3):600-10. PubMed ID: 1159064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of secretin-stimulated insulin responses in man.
    Lerner RL; Porte D
    J Clin Invest; 1972 Aug; 51(8):2205-10. PubMed ID: 4559947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Furosemide intravenous infusion in normal man: electrolytic, metabolic and hormonal effects. Lack of changes in basal insulin and glucagon plasma levels.
    Luyckx AS; Mendoza E; Lefebvre P
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):305-13. PubMed ID: 7013722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; D'Onofrio F
    Diabetes; 1988 Sep; 37(9):1265-70. PubMed ID: 2970411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.